By health
Byhealth Co., Ltd, together with its subsidiaries, provides dietary supplements in Mainland China, Hong Kong, Australia, and internationally. The company offers protein powder; collagen; bone health products, such as glucosamine, chondroitin, and calcium tablets; probiotics; capsules; and multivitamins. It sells its products under the By-Health, Jianli, LifeSpace and other brands through retail t… Read more
By health (300146) - Net Assets
Latest net assets as of September 2025: CN¥11.40 Billion CNY
Based on the latest financial reports, By health (300146) has net assets worth CN¥11.40 Billion CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥14.00 Billion) and total liabilities (CN¥2.60 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥11.40 Billion |
| % of Total Assets | 81.4% |
| Annual Growth Rate | 44.12% |
| 5-Year Change | 59.85% |
| 10-Year Change | 143.69% |
| Growth Volatility | 329.25 |
By health - Net Assets Trend (2007–2024)
This chart illustrates how By health's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for By health (2007–2024)
The table below shows the annual net assets of By health from 2007 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥11.10 Billion | -9.35% |
| 2023-12-31 | CN¥12.24 Billion | +13.82% |
| 2022-12-31 | CN¥10.76 Billion | +2.09% |
| 2021-12-31 | CN¥10.54 Billion | +51.77% |
| 2020-12-31 | CN¥6.94 Billion | +17.04% |
| 2019-12-31 | CN¥5.93 Billion | -13.89% |
| 2018-12-31 | CN¥6.89 Billion | +34.22% |
| 2017-12-31 | CN¥5.13 Billion | +9.10% |
| 2016-12-31 | CN¥4.70 Billion | +3.29% |
| 2015-12-31 | CN¥4.55 Billion | +86.05% |
| 2014-12-31 | CN¥2.45 Billion | +9.63% |
| 2013-12-31 | CN¥2.23 Billion | +15.86% |
| 2012-12-31 | CN¥1.93 Billion | +9.74% |
| 2011-12-31 | CN¥1.76 Billion | +8.11% |
| 2010-12-31 | CN¥1.62 Billion | +1418.04% |
| 2009-12-31 | CN¥107.00 Million | +153.12% |
| 2008-12-31 | CN¥42.27 Million | +90.37% |
| 2007-12-31 | CN¥22.21 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to By health's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 27888.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥2.68 Billion | 24.25% |
| Common Stock | CN¥1.70 Billion | 15.39% |
| Other Comprehensive Income | CN¥818.74 Million | 7.41% |
| Other Components | CN¥5.85 Billion | 52.95% |
| Total Equity | CN¥11.05 Billion | 100.00% |
By health Competitors by Market Cap
The table below lists competitors of By health ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Ouster, Inc. Common Stock
NYSE:OUST
|
$1.42 Billion |
|
NCINO INC. DL -0005
F:6NCA
|
$1.42 Billion |
|
VERITEX HLDGS INC. DL-01
F:47Y
|
$1.42 Billion |
|
AddLife AB (publ)
ST:ALIF-B
|
$1.42 Billion |
|
Glarun Technology Co Ltd
SHG:600562
|
$1.42 Billion |
|
Aroundtown SA
PINK:AANNF
|
$1.42 Billion |
|
AtriCure Inc
NASDAQ:ATRC
|
$1.42 Billion |
|
The Ramco Cements Limited
NSE:RAMCOCEM
|
$1.42 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in By health's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 12,166,989,799 to 11,050,967,843, a change of -1,116,021,956 (-9.2%).
- Net income of 652,833,810 contributed positively to equity growth.
- Dividend payments of 1,516,597,600 reduced retained earnings.
- Share repurchases of 241,702,034 reduced equity.
- Other comprehensive income increased equity by 818,744,721.
- Other factors decreased equity by 829,300,853.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥652.83 Million | +5.91% |
| Dividends Paid | CN¥1.52 Billion | -13.72% |
| Share Repurchases | CN¥241.70 Million | -2.19% |
| Other Comprehensive Income | CN¥818.74 Million | +7.41% |
| Other Changes | CN¥-829.30 Million | -7.5% |
| Total Change | CN¥- | -9.17% |
Book Value vs Market Value Analysis
This analysis compares By health's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.82x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1647.75x to 1.82x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-12-31 | CN¥0.01 | CN¥11.73 | x |
| 2008-12-31 | CN¥0.06 | CN¥11.73 | x |
| 2009-12-31 | CN¥0.12 | CN¥11.73 | x |
| 2010-12-31 | CN¥1.65 | CN¥11.73 | x |
| 2011-12-31 | CN¥1.33 | CN¥11.73 | x |
| 2012-12-31 | CN¥1.46 | CN¥11.73 | x |
| 2013-12-31 | CN¥1.69 | CN¥11.73 | x |
| 2014-12-31 | CN¥1.85 | CN¥11.73 | x |
| 2015-12-31 | CN¥3.16 | CN¥11.73 | x |
| 2016-12-31 | CN¥3.24 | CN¥11.73 | x |
| 2017-12-31 | CN¥3.46 | CN¥11.73 | x |
| 2018-12-31 | CN¥3.85 | CN¥11.73 | x |
| 2019-12-31 | CN¥4.04 | CN¥11.73 | x |
| 2020-12-31 | CN¥4.39 | CN¥11.73 | x |
| 2021-12-31 | CN¥6.17 | CN¥11.73 | x |
| 2022-12-31 | CN¥6.29 | CN¥11.73 | x |
| 2023-12-31 | CN¥7.18 | CN¥11.73 | x |
| 2024-12-31 | CN¥6.43 | CN¥11.73 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently By health utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.91%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 9.55%
- • Asset Turnover: 0.48x
- • Equity Multiplier: 1.29x
- Recent ROE (5.91%) is below the historical average (20.06%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | 54.61% | 18.14% | 1.49x | 2.03x | CN¥9.91 Million |
| 2008 | 63.17% | 18.99% | 1.82x | 1.83x | CN¥22.48 Million |
| 2009 | 48.76% | 25.41% | 1.37x | 1.40x | CN¥41.47 Million |
| 2010 | 5.67% | 26.61% | 0.20x | 1.08x | CN¥-70.33 Million |
| 2011 | 10.62% | 28.66% | 0.34x | 1.08x | CN¥10.82 Million |
| 2012 | 14.55% | 26.28% | 0.51x | 1.09x | CN¥87.64 Million |
| 2013 | 18.89% | 28.45% | 0.60x | 1.10x | CN¥198.41 Million |
| 2014 | 20.53% | 29.48% | 0.63x | 1.10x | CN¥257.83 Million |
| 2015 | 13.93% | 28.04% | 0.46x | 1.08x | CN¥179.29 Million |
| 2016 | 11.44% | 23.18% | 0.43x | 1.14x | CN¥67.21 Million |
| 2017 | 15.02% | 24.63% | 0.51x | 1.20x | CN¥256.17 Million |
| 2018 | 17.92% | 23.03% | 0.44x | 1.75x | CN¥443.01 Million |
| 2019 | -5.94% | -6.76% | 0.63x | 1.39x | CN¥-955.11 Million |
| 2020 | 21.98% | 25.01% | 0.63x | 1.39x | CN¥830.90 Million |
| 2021 | 16.71% | 23.60% | 0.57x | 1.24x | CN¥704.58 Million |
| 2022 | 12.96% | 17.63% | 0.60x | 1.23x | CN¥316.52 Million |
| 2023 | 14.35% | 18.56% | 0.62x | 1.24x | CN¥529.61 Million |
| 2024 | 5.91% | 9.55% | 0.48x | 1.29x | CN¥-452.26 Million |
Industry Comparison
This section compares By health's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $2,496,572,190
- Average return on equity (ROE) among peers: -3.76%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| By health (300146) | CN¥11.40 Billion | 54.61% | 0.23x | $1.42 Billion |
| Xiwang Foodstuffs Co Ltd (000639) | $65.61 Million | -62.17% | 1.91x | $345.26 Million |
| Nanfang Black Sesame Group Co Ltd (000716) | $199.49 Million | -32.62% | 2.81x | $346.21 Million |
| CNFC Overseas Fishery Co Ltd (000798) | $727.64 Million | 8.49% | 0.27x | $430.25 Million |
| Henan Shuanghui Investment & Development Co Ltd (000895) | $16.36 Billion | 24.69% | 0.34x | $3.98 Billion |
| Xinjiang Chalkis Co Ltd (000972) | $760.28 Million | -33.42% | 2.17x | $202.97 Million |
| Zhengzhou Qianweiyangchu Food Co Ltd (001215) | $332.95 Million | 17.62% | 0.88x | $266.09 Million |
| Wenzhou Yuanfei Pet Toy Products Co. Ltd. A (001222) | $1.35 Billion | 9.31% | 0.15x | $160.97 Million |
| Guangdong Yuehai Feeds Group Co.Ltd. (001313) | $2.07 Billion | 7.87% | 0.47x | $169.20 Million |
| Shandong Oriental Ocean Sci-Tech Co Ltd (002086) | $393.72 Million | 8.08% | 0.70x | $460.31 Million |
| Xinjiang Tecon Animal Husbandry Bio-Technology Co Ltd (002100) | $2.70 Billion | 14.52% | 0.66x | $903.18 Million |